Illustrative concept image.
Purpose & realistic expectations
Exosomes carry biological signals between cells. Laboratory findings do not establish that a marketed product improves skin or hair in people. Product source, purification, storage and clinical study quality must be assessed separately.
Assessment & planning
Your consultation reviews medical history, allergies, current medicines, prior procedures and your goals. Examination and product-specific information guide the decision. You can choose to defer treatment.
Precautions & limitations
The FDA has warned about unapproved exosome products. Foreign regulatory information does not establish Egyptian authorization. REVIVE does not offer exosome injection or microneedling delivery through this website. Local product-specific verification remains pending.
Availability & next steps
This page supports informed discussion and does not offer a product, procedure or research treatment. Clinical suitability and Egyptian regulatory status require product-specific verification.
Frequently asked questions
Is this available now?
This page supports informed discussion and does not offer a product, procedure or research treatment. Clinical suitability and Egyptian regulatory status require product-specific verification.
How is suitability decided?
Your consultation reviews medical history, allergies, current medicines, prior procedures and your goals. Examination and product-specific information guide the decision. You can choose to defer treatment.
References & further reading
FDA — Public safety notification on exosome productsContent prepared 15 November 2026. Formal medical review pending. No reviewer or approval is implied. This information supports, and does not replace, an individualized clinical consultation.